These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 25360689

  • 1. Synthesis, antitumor activity, and mechanism of action of benzo[b]chromeno[6,5-g][1,8]naphthyridin-7-one analogs of acronycine.
    Tian W, Yougnia R, Depauw S, Lansiaux A, David-Cordonnier MH, Pfeiffer B, Kraus-Berthier L, Léonce S, Pierré A, Dufat H, Michel S.
    J Med Chem; 2014 Dec 26; 57(24):10329-42. PubMed ID: 25360689
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and cytotoxic activity of benzo[a]acronycine and benzo[b]acronycine substituted on the A ring.
    Gaslonde T, Covello F, Velazquez-Alonso L, Léonce S, Pierré A, Pfeiffer B, Michel S, Tillequin F.
    Eur J Med Chem; 2011 May 26; 46(5):1861-73. PubMed ID: 21411193
    [Abstract] [Full Text] [Related]

  • 3. Synthesis, antitumor activity, and mechanism of action of benzo[a]pyrano[3,2-h]acridin-7-one analogues of acronycine.
    Nguyen TM, Sittisombut C, Boutefnouchet S, Lallemand MC, Michel S, Koch M, Tillequin F, Mazinghien R, Lansiaux A, David-Cordonnier MH, Pfeiffer B, Kraus-Berthier L, Léonce S, Pierré A.
    J Med Chem; 2006 Jun 01; 49(11):3383-94. PubMed ID: 16722658
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and cytotoxic and antitumor activity of benzo[b]pyrano[3, 2-h]acridin-7-one analogues of acronycine.
    Costes N, Le Deit H, Michel S, Tillequin F, Koch M, Pfeiffer B, Renard P, Léonce S, Guilbaud N, Kraus-Berthier L, Pierré A, Atassi G.
    J Med Chem; 2000 Jun 15; 43(12):2395-402. PubMed ID: 10882366
    [Abstract] [Full Text] [Related]

  • 5. Straightforward synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents of hybrid Chromeno[4,3-b][1,5]Naphthyridines and Chromeno[4,3-b][1,5]Naphthyridin-6-ones.
    Martín-Encinas E, Rubiales G, Knudssen BR, Palacios F, Alonso C.
    Eur J Med Chem; 2019 Sep 15; 178():752-766. PubMed ID: 31229877
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and cytotoxic and antitumor activity of 1,2-dihydroxy-1,2-dihydrobenzo[b]acronycine diacid hemiesters and carbamates.
    Doan Thi Mai H, Gaslonde T, Michel S, Koch M, Tillequin F, Pfeiffer B, Renard P, Kraus-Berthier L, Léonce S, Pierré A.
    Chem Pharm Bull (Tokyo); 2004 Mar 15; 52(3):293-7. PubMed ID: 14993749
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and cytotoxic activity of benzo[a]pyrano[3,2-h] and [2,3-i]xanthone analogues of psorospermine, acronycine, and benzo[a]acronycine.
    Sittisombut C, Boutefnouchet S, Trinh Van-Dufat H, Tian W, Michel S, Koch M, Tillequin F, Pfeiffer B, Pierré A.
    Chem Pharm Bull (Tokyo); 2006 Aug 15; 54(8):1113-8. PubMed ID: 16880654
    [Abstract] [Full Text] [Related]

  • 8. Development of 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and their salts as potent cytotoxic agents and topoisomerase I/IIα inhibitors.
    Arepalli SK, Lee C, Sim S, Lee K, Jo H, Jun KY, Kwon Y, Kang JS, Jung JK, Lee H.
    Bioorg Med Chem; 2018 Oct 01; 26(18):5181-5193. PubMed ID: 30253887
    [Abstract] [Full Text] [Related]

  • 9. Structure-activity relationships in the acronycine and benzo[b]acronycine series: role of the pyran ring.
    Do Q, Thi Mai HD, Gaslonde T, Pfeiffer B, Léonce S, Pierré A, Michel S, Tillequin F, Dufat H.
    Eur J Med Chem; 2008 Dec 01; 43(12):2677-87. PubMed ID: 18342404
    [Abstract] [Full Text] [Related]

  • 10. Structure-activity relationships and mechanism of action of antitumor benzo[b]pyrano[3,2-h]acridin-7-one acronycine analogues.
    Thi Mai HD, Gaslonde T, Michel S, Tillequin F, Koch M, Bongui JB, Elomri A, Seguin E, Pfeiffer B, Renard P, David-Cordonnier MH, Laine W, Bailly C, Kraus-Berthier L, Léonce S, Hickman JA, Pierré A.
    J Med Chem; 2003 Jul 03; 46(14):3072-82. PubMed ID: 12825945
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and cytotoxic activity of acronycine derivatives modified at the pyran ring.
    Elomri A, Skaltsounis AL, Michel S, Tillequin F, Koch M, Rolland Y, Pierré A, Atassi G.
    Chem Pharm Bull (Tokyo); 1996 Nov 03; 44(11):2165-8. PubMed ID: 8945782
    [Abstract] [Full Text] [Related]

  • 12. Influence of the stereoisomeric position of the reactive acetate groups of the benzo[b]acronycine derivative S23906-1 on its DNA alkylation, helix-opening, cytotoxic, and antitumor activities.
    Depauw S, Gaslonde T, Léonce S, Kraus-Berthier L, Laine W, Lenglet G, Chiaroni A, Pfeiffer B, Bailly C, Michel S, Tillequin F, Pierré A, David-Cordonnier MH.
    Mol Pharmacol; 2009 Dec 03; 76(6):1172-85. PubMed ID: 19752199
    [Abstract] [Full Text] [Related]

  • 13. Design, synthesis, and cytotoxic activity of Michael acceptors and enol esters in the benzo[b]acronycine series.
    Doan Thi Mai H, Gaslonde T, Michel S, Koch M, Tillequin F, Bailly C, David-Cordonnier MH, Pfeiffer B, Léonce S, Pierré A.
    Chem Pharm Bull (Tokyo); 2005 Aug 03; 53(8):919-22. PubMed ID: 16079520
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and cytotoxic and antitumor activity of esters in the 1,2-dihydroxy-1,2-dihydroacronycine series.
    Elomri A, Mitaku S, Michel S, Skaltsounis AL, Tillequin F, Koch M, Pierré A, Guilbaud N, Léonce S, Kraus-Berthier L, Rolland Y, Atassi G.
    J Med Chem; 1996 Nov 22; 39(24):4762-6. PubMed ID: 8941390
    [Abstract] [Full Text] [Related]

  • 15. Novel derivatives of pyridylbenzo[b]thiophene-2-carboxamides and benzo[b]thieno[2,3-c]naphthyridin-2-ones: minor structural variations provoke major differences of antitumor action mechanisms.
    Ester K, Hranjec M, Piantanida I, Caleta I, Jarak I, Pavelić K, Kralj M, Karminski-Zamola G.
    J Med Chem; 2009 Apr 23; 52(8):2482-92. PubMed ID: 19331416
    [Abstract] [Full Text] [Related]

  • 16. Benzo[b]acronycine derivatives: a novel class of antitumor agents.
    Michel S, Gaslonde T, Tillequin F.
    Eur J Med Chem; 2004 Aug 23; 39(8):649-55. PubMed ID: 15276298
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis and anticancer activity of novel dihydrobenzofuro[4,5-b][1,8]naphthyridin-6-one derivatives.
    Kang JA, Yang Z, Lee JY, De U, Kim TH, Park JY, Lee HJ, Park YJ, Chun P, Kim HS, Jeong LS, Moon HR.
    Bioorg Med Chem Lett; 2011 Oct 01; 21(19):5730-4. PubMed ID: 21885273
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and cytotoxic activity of carboxamide derivatives of benzo[b][1,6]naphthyridin-(5H)ones.
    Deady LW, Rogers ML, Zhuang L, Baguley BC, Denny WA.
    Bioorg Med Chem; 2005 Feb 15; 13(4):1341-55. PubMed ID: 15670942
    [Abstract] [Full Text] [Related]

  • 19. [From acronycine to benzo-[b]-acronycine derivatives: potent antitumor agents].
    Koch M.
    Bull Acad Natl Med; 2007 Jan 15; 191(1):83-91; discussion 91-3. PubMed ID: 17645109
    [Abstract] [Full Text] [Related]

  • 20. Synthesis, cytotoxic activity, and DNA binding properties of antitumor cis-1,2-dihydroxy-1,2-dihydrobenzo[b]acronycine cinnamoyl esters.
    Do Q, Tian W, Yougnia R, Gaslonde T, Pfeiffer B, Pierré A, Léonce S, Kraus-Berthier L, David-Cordonnier MH, Depauw S, Lansiaux A, Mazinghien R, Koch M, Tillequin F, Michel S, Dufat H.
    Bioorg Med Chem; 2009 Mar 01; 17(5):1918-27. PubMed ID: 19217791
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.